Agenus (AGEN) Revenue & Revenue Breakdown

Overview ForecastOwnership Financials Chart Transcripts

Agenus Revenue Highlights

Latest Revenue (Y)

$114.20M

Latest Revenue (Q)

$30.23M

Main Segment (Y)

Non Cash Royalty Revenue

Main Geography (Y)

UNITED STATES

Agenus Revenue by Period

Agenus Revenue by Year

Date	Revenue	Change
2025-12-31	$114.20M	10.37%
2024-12-31	$103.46M	-33.81%
2023-12-31	$156.31M	59.47%
2022-12-31	$98.02M	-66.85%
2021-12-31	$295.67M	235.34%
2020-12-31	$88.17M	-41.24%
2019-12-31	$150.05M	307.92%
2018-12-31	$36.78M	-14.21%
2017-12-31	$42.88M	89.95%
2016-12-31	$22.57M	-9.04%
2015-12-31	$24.82M	255.70%
2014-12-31	$6.98M	129.13%
2013-12-31	$3.04M	-80.92%
2012-12-31	$15.96M	479.18%
2011-12-31	$2.76M	-17.97%
2010-12-31	$3.36M	0.77%
2009-12-31	$3.33M	25.76%
2008-12-31	$2.65M	-52.25%
2007-12-31	$5.55M	702.20%
2006-12-31	$692.13K	9.87%
2005-12-31	$629.98K	-10.90%
2004-12-31	$707.07K	-84.11%
2003-12-31	$4.45M	30.43%
2002-12-31	$3.41M	-25.10%
2001-12-31	$4.55M	929.08%
2000-12-31	$442.63K	342.63%
1999-12-31	$100.00K	-

Agenus generated $114.20M in revenue during NA 2025, up 10.37% compared to the previous quarter, and up 129.52% compared to the same period a year ago.

Agenus Revenue by Quarter

Date	Revenue	Change
2025-09-30	$30.23M	17.69%
2025-06-30	$25.69M	6.75%
2025-03-31	$24.07M	-10.33%
2024-12-31	$26.84M	6.87%
2024-09-30	$25.11M	6.82%
2024-06-30	$23.51M	-16.05%
2024-03-31	$28.00M	-66.58%
2023-12-31	$83.80M	244.66%
2023-09-30	$24.31M	-3.88%
2023-06-30	$25.30M	10.45%
2023-03-31	$22.90M	-19.32%
2022-12-31	$28.39M	24.65%
2022-09-30	$22.77M	8.82%
2022-06-30	$20.93M	-19.33%
2022-03-31	$25.94M	28.03%
2021-12-31	$20.26M	-91.99%
2021-09-30	$252.95M	2257.45%
2021-06-30	$10.73M	-8.44%
2021-03-31	$11.72M	-62.52%
2020-12-31	$31.26M	110.79%
2020-09-30	$14.83M	-44.95%
2020-06-30	$26.95M	78.11%
2020-03-31	$15.13M	-56.15%
2019-12-31	$34.50M	73.02%
2019-09-30	$19.94M	26.89%
2019-06-30	$15.71M	-80.33%
2019-03-31	$79.89M	1138.53%
2018-12-31	$6.45M	-49.62%
2018-09-30	$12.80M	-19.45%
2018-06-30	$15.89M	871.53%
2018-03-31	$1.64M	-80.42%
2017-12-31	$8.35M	148.68%
2017-09-30	$3.36M	-20.15%
2017-06-30	$4.21M	-84.39%
2017-03-31	$26.96M	383.43%
2016-12-31	$5.58M	25.42%
2016-09-30	$4.45M	-32.55%
2016-06-30	$6.59M	10.62%
2016-03-31	$5.96M	-21.99%
2015-12-31	$7.64M	11.55%
2015-09-30	$6.85M	7.39%
2015-06-30	$6.38M	61.30%
2015-03-31	$3.95M	144.16%
2014-12-31	$1.62M	3.57%
2014-09-30	$1.56M	-49.14%
2014-06-30	$3.07M	326.45%
2014-03-31	$720.86K	83.62%
2013-12-31	$392.58K	-46.66%
2013-09-30	$735.99K	-8.84%
2013-06-30	$807.40K	-27.21%
2013-03-31	$1.11M	1.75%
2012-12-31	$1.09M	25.48%
2012-09-30	$868.80K	38.61%
2012-06-30	$626.79K	-95.31%
2012-03-31	$13.37M	1977.57%
2011-12-31	$643.78K	-1.51%
2011-09-30	$653.68K	-16.88%
2011-06-30	$786.43K	17.05%
2011-03-31	$671.88K	-32.38%
2010-12-31	$993.56K	59.11%
2010-09-30	$624.45K	-22.45%
2010-06-30	$805.17K	-14.02%
2010-03-31	$936.43K	71.26%
2009-12-31	$546.79K	-39.01%
2009-09-30	$896.46K	-29.40%
2009-06-30	$1.27M	104.37%
2009-03-31	$621.35K	19.13%
2008-12-31	$521.58K	-23.81%
2008-09-30	$684.57K	15.11%
2008-06-30	$594.71K	-30.05%
2008-03-31	$850.22K	-4.82%
2007-12-31	$893.29K	-

Agenus generated $30.23M in revenue during Q3 2025, up 17.69% compared to the previous quarter, and up 128.61% compared to the same period a year ago.

Agenus Revenue Breakdown

Agenus Revenue Breakdown by Product

Annual Revenue by Product

Product/Service	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
Non Cash Royalty Revenue	$108.59M	$100.98M	$114.57M	-	-
Other	$1.04M	$2.00M	-	-	-
License Fee Revenue	-	-	$25.00M	-	-
Non Cash Royalty Revenue Related To The Sale Of Future Royalties And Milestone	-	-	-	$45.28M	-
Research And Development Revenue	-	-	-	$1.60M	$1.20M
Product And Service Other	-	-	-	-	$184.00K
Revenue	-	-	-	-	$6.70M

Agenus's latest annual revenue breakdown by segment (product or service), as of Dec 25: Non Cash Royalty Revenue (99.05%), and Other (0.95%).

Quarterly Revenue by Product

Product/Service	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Mar 24	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20
Other	-	$1.04M	$526.00K	$510.00K	$1.55M	$454.00K	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Non Cash Royalty Revenue	$31.05M	$29.15M	$24.83M	$23.56M	$76.32M	$24.66M	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Research And Development Revenue	-	-	-	-	-	-	-	$3.41M	$2.49M	$2.61M	$3.75M	$4.57M	$1.91M	$6.74M	$1.71M	$1.57M	$11.63M	$4.29M	-	-
Revenue	-	-	-	-	-	-	$238.00K	$540.00K	$739.00K	$1.18M	$6.35M	$1.04M	$1.56M	$1.57M	$2.50M	$1.38M	$1.20M	$1.63M	$2.00M	$1.60M
Product And Service Other	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$149.00K	-	-	$35.00K	$39.00K	-

Agenus's latest quarterly revenue breakdown by segment (product or service), as of Dec 25: Non Cash Royalty Revenue (100.00%).

Agenus Revenue Breakdown by Country

Annual Revenue by Country

Country	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
Non-US	$1.04M	$2.00M	-	-	-
UNITED STATES	$113.16M	$101.46M	$114.57M	$9.54M	$288.96M
Non Us	-	-	-	-	$6.70M

Agenus's latest annual revenue breakdown by geography, as of Dec 25: UNITED STATES (99.09%), and Non-US (0.91%).

Quarterly Revenue by Country

Country	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20
Non-US	-	$1.04M	$526.00K	$510.00K	$1.55M	$454.00K	-	-	-	-	-	-	-	-	-	-	-	-	-	-
UNITED STATES	$34.20M	$30.23M	$25.16M	$23.56M	$49.03M	$24.66M	$27.77M	$89.82M	$20.36M	$2.04M	$2.35M	$18.28M	$4.45M	$19.37M	$24.37M	$17.76M	$9.53M	$10.09M	$29.31M	-
Non Us	-	-	-	-	-	-	-	-	-	-	-	-	-	$1.56M	$1.57M	$2.50M	$1.38M	$1.20M	$1.63M	$1.95M
U S	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$251.58M	-	-	-

Agenus's latest quarterly revenue breakdown by geography, as of Dec 25: UNITED STATES (100.00%).

Agenus Peer Comparison by Revenue

Ticker	Company	Last Year Revenue	Last Quarter Revenue
AGEN	Agenus	$114.20M	$30.23M
SEER	Seer	$16.58M	$4.12M
FATE	Fate Therapeutics	$6.65M	$1.91M
VTGN	VistaGen Therapeutics	$1.06M	$303.00K
ZNTL	Zentalis Pharmaceuticals	-	-
IRD	Opus Genetics	-	-
INO	Inovio Pharmaceuticals	-	-
ABOS	Acumen Pharmaceuticals	-	-
TTRX	Turn Therapeutics	-	-
PLRX	Pliant Therapeutics	-	-
HURA	TuHURA Biosciences	-	-

AGEN Revenue FAQ

What is Agenus’s yearly revenue?

Agenus's yearly revenue for 2025 was $114.2M, representing an increase of 10.37% compared to 2024. The company's yearly revenue for 2024 was $103.46M, representing a decrease of -33.81% compared to 2023. AGEN's yearly revenue for 2023 was $156.31M, representing an increase of 59.47% compared to 2022.

What is Agenus’s quarterly revenue?

Agenus's quarterly revenue for Q3 2025 was $30.24M, a 17.69% increase from the previous quarter (Q2 2025), and a 20.40% increase year-over-year (Q3 2024). The company's quarterly revenue for Q2 2025 was $25.69M, a 6.75% increase from the previous quarter (Q1 2025), and a 9.28% increase year-over-year (Q2 2024). AGEN's quarterly revenue for Q1 2025 was $24.07M, a -10.33% decrease from the previous quarter (Q4 2024), and a -14.07% decrease year-over-year (Q1 2024).

What is Agenus’s revenue growth rate?

Agenus's revenue growth rate for the last 3 years (2023-2025) was -26.94%, and for the last 5 years (2021-2025) was -61.38%.

What are Agenus’s revenue streams?

Agenus's revenue streams in c 25 are Non Cash Royalty Revenue, and Other. Non Cash Royalty Revenue generated $108.59M in revenue, accounting 99.05% of the company's total revenue, up 7.54% year-over-year. Other generated $1.04M in revenue, accounting 0.95% of the company's total revenue, down -48.28% year-over-year.

What is Agenus’s main source of revenue?

For the fiscal year ending Dec 25, the largest source of revenue of Agenus was Non Cash Royalty Revenue. This segment made a revenue of $108.59M, representing 99.05% of the company's total revenue.